AEON Biopharma, Inc.

Ownership Transactions Reported by 14 Insiders

Symbol
AEON on NYSE
Industry
Pharmaceutical Preparations
Location
5 Park Plaza, Suite 1750, Irvine, California

There are no Buy or Sell transactions made by insiders since 9/11/2023

AEON Biopharma, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Priveterra Sponsor, LLC 10%+ Owner $139M Jul 21, 2023
Strathspey Crown Holdings Group, LLC 10%+ Owner $20.3M Aug 11, 2023
Palmisano Robert J Director Aug 31, 2024
Jost Fischer Director Aug 31, 2024
Eric G. Carter Director Aug 31, 2024
Shelley B. Thunen Director Aug 31, 2024
Jennifer Sy Principal Accounting Officer Aug 31, 2024
Seongsoo Park Director Apr 12, 2024
Chad Oh Chief Medical Officer Aug 31, 2024
Alexander Wilson Exec Vp, Clo & Corp Secretary Aug 31, 2024
Daewoong Co., Ltd 10%+ Owner Apr 12, 2024
Marc Forth CHIEF EXECTUIVE OFFICER, Director Aug 31, 2024
Peter A. Reynolds Chief Financial Officer Jul 21, 2023
Barclays Plc 10%+ Owner Feb 20, 2023

Recent Insider Transactions by Companies or Individuals for AEON Biopharma, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.